Sort
48,018 grants matching “immunotherapy”
RADIOIMMUNOTHERAPY USING BISPECIFIC ANTIBODIES
$442,937Immunomedics, Inc. · R44 · FY2000 · CA
Developmental Funds
$442,936Primo N Lara · University Of California At Davis · P30 · FY2020 · CA
DPT-1 / TrialNet
$442,935University Of Colorado Denver · U01 · FY2004 · DK
Targeting convergent oncogenic signaling during AR inhibition to overcome metastasis and immune evasion in prostate cancer
$442,930Andrew J Armstrong · Duke University · R01 · FY2023 · CA
Mitochondrial R-loop in sepsis-induced cardiomyopathy
$442,907Wei Huang · University Of Cincinnati · R01 · FY2024 · HL
Immunometabolic Regulation of Adipose Tissue by CTRP6
$442,844Xia Lei · Oklahoma State University Stillwater · R15 · FY2024 · DK
Using Nonclassical Estrogen Signaling to Prevent Melanoma
$442,834Todd W Ridky · University Of Pennsylvania · R01 · FY2020 · CA
MRI of tumor-infiltrating lymphocytes using MRI-cytometry
$442,824Junzhong Xu · Vanderbilt University Medical Center · R01 · FY2024 · CA
Investigational Cancer Therapeutics Training Program
$442,811Mark G Kris · Sloan-Kettering Inst Can Research · T32 · FY2016 · CA
Augmenting Antitumor Immunity
$442,759Hyam Isaac Levitsky · Johns Hopkins University · P01 · FY2015 · CA
Augmenting Antitumor Immunity
$442,759Hyam Isaac Levitsky · Johns Hopkins University · P01 · FY2016 · CA
Is Low Tumor Mutational Burden Predictive of Response to Oncolytic Polio Virus Therapy in Recurrent Glioblastoma?
$442,750David M. Ashley · Duke University · R21 · FY2019 · NS
Novel IL-12 Gene Delivery Vehicles for Transformation of Solid Tumors
$442,717Seth M Pollack · Northwestern University At Chicago · R01 · FY2021 · CA
Liquid biopsy-based toolkits for neoantigen and cognate TCR discovery for cancer immunotherapy
$442,712Wei Wei · Institute For Systems Biology · R33 · FY2023 · CA
Mathematical modeling and molecular imaging to maximize response while minimizing toxicities from systemic therapies in preclinical models of breast cancer
$442,688Anna C Sorace · University Of Alabama At Birmingham · R01 · FY2024 · CA
IMPROVED SECOND ANTIBODY RADIOIMMUNOTHERAPY OF CANCER
$442,644Ctr For Molecular Medicine/Immunology · R01 · FY2000 · CA
Protection of the Heart by PD-1 and PD-L1
$442,623Andrew H Lichtman · Brigham And Women'S Hospital · R01 · FY2014 · HL
Repertoire selection of AQP4-specific T cells that cause CNS autoimmunedisease
$442,563Scott S Zamvil · University Of California, San Francisco · R01 · FY2022 · AI
Cell migration and cell-cell interactions in bone marrow
$442,536Ulrich H Von Andrian · Immune Disease Institute, Inc. · P01 · FY2008 · HL
Structural and functional analyses of the RIG-I filament in innate immunity
$442,500Sun Hur · Boston Children'S Hospital · R01 · FY2017 · AI
Molecular Mechanisms for Antiviral Signal Activation by MDA5 and RIG-I
$442,500Sun Hur · Boston Children'S Hospital · R01 · FY2017 · AI
Project III: Engineering immunogenic cell death in melanoma and renal cell carcinoma.
$442,500Emily H Cheng · Sloan-Kettering Inst Can Research · U54 · FY2025 · CA
Structural and functional analyses of the RIG-I filament in innate immunity
$442,500Sun Hur · Boston Children'S Hospital · R01 · FY2016 · AI
Control of Airway Tolerance
$442,500Michael Croft · La Jolla Institute For Immunology · R01 · FY2015 · AI
Control of Airway Tolerance
$442,500Michael Croft · La Jolla Institute For Immunology · R01 · FY2014 · AI